A new coumarin was obtained from the stems and roots of Wikstroemia indica （L.） C. A. Mey. Its structure was elucidated as methyl 3-（2-hydroxy-4-（7-hydroxy-6-methoxy-2-oxo-2H-chromen-3-yloxy） phenyl） propanoate ...A new coumarin was obtained from the stems and roots of Wikstroemia indica （L.） C. A. Mey. Its structure was elucidated as methyl 3-（2-hydroxy-4-（7-hydroxy-6-methoxy-2-oxo-2H-chromen-3-yloxy） phenyl） propanoate by spectroscopic methods.展开更多
Wiksroemia indica belongs to the family of Thymelaeaceae.As a material of Traditional Chinese Medicine,it is mainly used to treat inflammation-related diseases.However,due to its complex composition,the scientific bas...Wiksroemia indica belongs to the family of Thymelaeaceae.As a material of Traditional Chinese Medicine,it is mainly used to treat inflammation-related diseases.However,due to its complex composition,the scientific basis for its traditional application is still insufficient and the mechanism of action is still unclear.At present,most studies on its anti-inflammatory effect focus on a certain component and its different solvent fractions.There are few reports about the synergistic mechanism of the constituents from W.indica for the treatment of inflammatory diseases.Therefore,the present study aimed to uncover its potential mechanism from a holistic perspective using the network pharmacology approach.Firstly,compounds in W.indica and genes associated with inflammatory diseases were obtained.Then,the active compounds were screened out and their targets were predicted.After that,the key targets for W.indica to treat inflammatory diseases were screened out.Finally,the protein-protein interaction(PPI),Gene ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analyses of key targets were performed to further study the mechanism of W.indica in the treatment of inflammatory diseases.The results showed that the active constituents of W.indica might play an anti-inflammatory role through the key targets CYP19A1 and CYP1B1,which clarified the primary mechanism for the treatment of inflammatory diseases and provided a scientific basis for further study of this herb.展开更多
文摘A new coumarin was obtained from the stems and roots of Wikstroemia indica （L.） C. A. Mey. Its structure was elucidated as methyl 3-（2-hydroxy-4-（7-hydroxy-6-methoxy-2-oxo-2H-chromen-3-yloxy） phenyl） propanoate by spectroscopic methods.
文摘Wiksroemia indica belongs to the family of Thymelaeaceae.As a material of Traditional Chinese Medicine,it is mainly used to treat inflammation-related diseases.However,due to its complex composition,the scientific basis for its traditional application is still insufficient and the mechanism of action is still unclear.At present,most studies on its anti-inflammatory effect focus on a certain component and its different solvent fractions.There are few reports about the synergistic mechanism of the constituents from W.indica for the treatment of inflammatory diseases.Therefore,the present study aimed to uncover its potential mechanism from a holistic perspective using the network pharmacology approach.Firstly,compounds in W.indica and genes associated with inflammatory diseases were obtained.Then,the active compounds were screened out and their targets were predicted.After that,the key targets for W.indica to treat inflammatory diseases were screened out.Finally,the protein-protein interaction(PPI),Gene ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analyses of key targets were performed to further study the mechanism of W.indica in the treatment of inflammatory diseases.The results showed that the active constituents of W.indica might play an anti-inflammatory role through the key targets CYP19A1 and CYP1B1,which clarified the primary mechanism for the treatment of inflammatory diseases and provided a scientific basis for further study of this herb.
